Loading, please wait ...


News Analytics

LEO logo black strapline FA 170905.
Kyntheum® (brodalumab) is the only fully human monoclonal antibody that selectively targets the IL-17 receptor subunit A.10,13 By binding to the receptor with high affinity, Kyntheum® effectively blocks the biological activity of several pro-inflammatory IL-17 cytokines, which are important in psoriasis.ý13,14 The psoriasis clinical studies programme for Kyntheum® consisted of three clinical trials; AMAGINE-1 (n=661), AMAGINE-2 (n=1831) and AMAGINE-3 (n=1881).15,16 ...
Google

Subject Matter

  • Healthcare 72.60%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 27.40%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions